PDE1C and cardiac hypertrophy: While PDE1C and PDE3A inhibitors attenuate cardiac hypertrophy and PDE3 inhibitors in the short term enhance LV contractility and overall systolic function, prolonged inhibition of PDE3 is detrimental because it promotes apoptosis and hypertrophy of the remaining cardiac myocytes [81].